Daxor Corp. announced that it has appointed Michael Feldschuh as Executive Vice President, to head business development and strategic initiatives for Daxor Corporation as part of the firm's effort to build its medical device business. Michael joins Daxor after having headed his own hedge fund, Aristarc Capital, from 2009 to 2013.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.79 USD | +0.06% | +3.41% | -8.44% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.44% | 44.5M | |
+5.79% | 13.02B | |
+17.03% | 9.99B | |
+1.80% | 5.69B | |
-1.17% | 5.47B | |
+30.45% | 5.2B | |
+5.13% | 5.16B | |
+24.44% | 4.76B | |
+3.73% | 4B | |
-2.89% | 3.83B |
- Stock Market
- Equities
- DXR Stock
- News Daxor Corporation
- Daxor Corp Appoints Michael Feldschuh as Executive Vice President